day 1 of tirzepatide TrimRX Here's to day 1! :

[51] found that linagliptin decreases aortic pulse wave velocity (PWV), a surrogate marker for arterial stiffness and early atherosclerosis, by an average of 0.91 m/s

For example, a patient struggling with a hallowing of the face might choose fillers or fat transfer for volume, combined with Ultherapy for skin tightening

Each batch undergoes third-party testing for purity, and the peptide is supplied in lyophilized powder form for maximum stability during shipping and storage

PMID 20153367

Seek medical attention if symptoms persist beyond 3 weeks or involve facial weakness

Presented for research literature review only avdarl K et al